<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">IBRO Rep</journal-id><journal-id journal-id-type="iso-abbrev">IBRO Rep</journal-id><journal-title-group><journal-title>IBRO Reports</journal-title></journal-title-group><issn pub-type="epub">2451-8301</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30135939</article-id><article-id pub-id-type="pmc">6084830</article-id><article-id pub-id-type="publisher-id">S2451-8301(17)30020-1</article-id><article-id pub-id-type="doi">10.1016/j.ibror.2017.07.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Interneurons secrete prosaposin, a neurotrophic factor, to attenuate kainic acid-induced neurotoxicity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nabeka</surname><given-names>Hiroaki</given-names></name><email>nabeka@m.ehime-u.ac.jp</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author"><name><surname>Saito</surname><given-names>Shouichiro</given-names></name><email>shouichi@gifu-u.ac.jp</email><xref rid="aff0010" ref-type="aff">b</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xuan</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Shimokawa</surname><given-names>Tetsuya</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Md. Sakirul Islam</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Yamamiya</surname><given-names>Kimiko</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Kawabe</surname><given-names>Soichiro</given-names></name><xref rid="aff0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Doihara</surname><given-names>Takuya</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Hamada</surname><given-names>Fumihiko</given-names></name><xref rid="aff0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Kobayashi</surname><given-names>Naoto</given-names></name><xref rid="aff0025" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Matsuda</surname><given-names>Seiji</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib></contrib-group><aff id="aff0005"><label>a</label>Department of Anatomy and Embryology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan</aff><aff id="aff0010"><label>b</label>Laboratory of Veterinary Anatomy, Faculty of Applied Biological Sciences, Gifu University, Yanagido, Gifu, Japan</aff><aff id="aff0015"><label>c</label>Fukui Prefectural Dinosaur Museum, Fukui, Japan</aff><aff id="aff0020"><label>d</label>Department of Human Anatomy, Oita University Fuculty of Medicine, Yufu, Oita, Japan</aff><aff id="aff0025"><label>e</label>Medical Education Center, Ehime University Graduate School of Medicine, Toon, Ehime, Japan</aff><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding authors. <email>nabeka@m.ehime-u.ac.jp</email><email>shouichi@gifu-u.ac.jp</email></corresp><fn id="fn0005"><label>1</label><p id="npar0005">Equal contribution. HN mainly contributes to immunohistochemistry, SS to in situ hybridization.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>22</day><month>8</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>12</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>22</day><month>8</month><year>2017</year></pub-date><volume>3</volume><fpage>17</fpage><lpage>32</lpage><history><date date-type="received"><day>17</day><month>4</month><year>2017</year></date><date date-type="rev-recd"><day>16</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 The Authors</copyright-statement><copyright-year>2017</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract abstract-type="author-highlights" id="abs0005"><title>Highlights</title><p><list list-type="simple" id="lis0005"><list-item id="lsti0005"><label>&#x02022;</label><p id="par0005">PS increased mainly in the axons of PV positive interneurons after kainic acid (KA) injection.</p></list-item><list-item id="lsti0010"><label>&#x02022;</label><p id="par0010">Electron microscopy revealed PS containing vesicles in PV positive axons.</p></list-item><list-item id="lsti0015"><label>&#x02022;</label><p id="par0015">PS is secreted with secretogranin from synapses.</p></list-item><list-item id="lsti0020"><label>&#x02022;</label><p id="par0020">The increased PS in the interneurons was due to increases in PS&#x000a0;+&#x000a0;0, as in the choroid plexus.</p></list-item><list-item id="lsti0025"><label>&#x02022;</label><p id="par0025">Interneurons produce and secrete intact PS around the hippocampal pyramidal neurons to protect them from KA neurotoxicity.</p></list-item></list></p></abstract><abstract id="abs0010"><p>Prosaposin (PS) is a secretory neurotrophic factor, as well as a regulator of lysosomal enzymes. We previously reported the up-regulation of PS and the possibility of its axonal transport by GABAergic interneurons after exocitotoxicity induced by kainic acid (KA), a glutamate analog. In the present study, we performed double immunostaining with PS and three calcium binding protein markers: parvalbumin (PV), calbindin, and calretinin, for the subpopulation of GABAergic interneurons, and clarified that the increased PS around the hippocampal pyramidal neurons after KA injection existed mainly in the axons of PV positive interneurons. Electron microscopy revealed PS containing vesicles in the PV positive axon. Double immunostaining with PS and secretogranin or synapsin suggested that PS is secreted with secretogranin from synapses. Based on the results from in situ hybridization with two alternative splicing forms of PS mRNA, the increase of PS in the interneurons was due to the increase of PS&#x000a0;+&#x000a0;0 (mRNA without 9-base insertion) as in the choroid plexus, but not PS&#x000a0;+&#x000a0;9 (mRNA with 9-base insertion). These results were similar to those from the choroid plexus, which secretes an intact form PS&#x000a0;+&#x000a0;0 to the cerebrospinal fluid. Neurons, especially PV positive GABAergic interneurons, produce and secrete the intact form of PS around hippocampal pyramidal neurons to protect them against KA neurotoxicity.</p></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Interneurons transport</kwd><kwd>Neurotrophic factor</kwd><kwd>Neuroprotection</kwd><kwd>Prosaposin</kwd><kwd>Kainic acid</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><label>1</label><title>Introduction</title><p id="par0030">Secretory neurotrophic factors including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 or 4/5 (NT-3 or NT-4/5) promote neuronal survival. Unlike other growth factors, which are secreted via a constitutive pathway, BDNF is sorted into a regulated pathway with sortilin in response to neuronal activity (<xref rid="bib0165" ref-type="bibr">Lou et al., 2005</xref>, <xref rid="bib0045" ref-type="bibr">Evans et al., 2011</xref>).</p><p id="par0035">Prosaposin (PS), a neurotrophic factor (<xref rid="bib0270" ref-type="bibr">Sano et al., 1994</xref>, <xref rid="bib0135" ref-type="bibr">Kotani et al., 1996a</xref>, <xref rid="bib0140" ref-type="bibr">Kotani et al., 1996b</xref>, <xref rid="bib0305" ref-type="bibr">Tsuboi et al., 1998</xref>, <xref rid="bib0060" ref-type="bibr">Gao et al., 2013a</xref>, <xref rid="bib0070" ref-type="bibr">Gao et al., 2016</xref>), is also secreted by a mechanism for regulated secretion with sortilin (<xref rid="bib0330" ref-type="bibr">Yuan and Morales, 2011</xref>). Previously, we have reported the possible PS secretion from the GABAergic interneurons via tau-positive axons around the hippocampal pyramidal neurons after kainic acid injection (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>). PS is originally reported to be the precursor protein of four small lysosomal glycoproteins, saposins A, B, C, and D (<xref rid="bib0255" ref-type="bibr">Sano et al., 1988</xref>, <xref rid="bib0215" ref-type="bibr">O'Brien et al., 1988</xref>, <xref rid="bib0220" ref-type="bibr">O'Brien and Kishimoto, 1991</xref>, <xref rid="bib0120" ref-type="bibr">Kishimoto et al., 1992</xref>). Both saposins and PS are widely expressed in various tissues, although the brain, skeletal muscle and heart cells predominantly contain unprocessed PS rather than saposins (<xref rid="bib0260" ref-type="bibr">Sano et al., 1989</xref>, <xref rid="bib0265" ref-type="bibr">Sano et al., 1992</xref>, <xref rid="bib0125" ref-type="bibr">Kondoh et al., 1991</xref>, <xref rid="bib0130" ref-type="bibr">Kondoh et al., 1993</xref>, <xref rid="bib0115" ref-type="bibr">Hosoda et al., 2007</xref>, <xref rid="bib0300" ref-type="bibr">Terashita et al., 2007</xref>). In addition, unprocessed PS is found in various secretory fluids, such as seminal plasma, bile, pancreatic juice, human breast milk and cerebrospinal fluid (<xref rid="bib0090" ref-type="bibr">Hineno et al., 1991</xref>, <xref rid="bib0095" ref-type="bibr">Hiraiwa et al., 1992</xref>), and PS mRNA is strongly expressed in the choroid plexus (<xref rid="bib0250" ref-type="bibr">Saito et al., 2014</xref>).</p><p id="par0040">Kainic acid (KA), a glutamate analogue, is a powerful neurotoxic agent (<xref rid="bib0230" ref-type="bibr">Olney and de Gubareff, 1978</xref>) that stimulates excitatory neurotransmitter release (<xref rid="bib0050" ref-type="bibr">Ferkany et al., 1982</xref>). Systemic KA injection induces neuronal degeneration in certain neuronal areas, including the hippocampus (<xref rid="bib0280" ref-type="bibr">Schwob et al., 1980</xref>, <xref rid="bib0200" ref-type="bibr">Nadler and Cuthbertson, 1980</xref>, <xref rid="bib0205" ref-type="bibr">Nadler et al., 1981</xref>, <xref rid="bib0085" ref-type="bibr">Heggli et al., 1981</xref>, <xref rid="bib0160" ref-type="bibr">Lothman and Collins, 1981</xref>, <xref rid="bib0195" ref-type="bibr">Nabeka et al., 2015</xref>). Hippocampal CA3 neurons are selectively vulnerable to KA, due to high levels of KA receptors in this region (<xref rid="bib0170" ref-type="bibr">Malva et al., 1998</xref>). KA can bind to the AMPA/KA receptors, and activation of its receptor has been shown to elicit a number of cellular events, including the increase in intracellular Ca2+, production of reactive oxygen species, and other biochemical events leading to neuronal cell death (see the review of <xref rid="bib0315" ref-type="bibr">Wang et al., 2005</xref>). This nature of neuronal degeneration caused by systemic KA injection resembles some forms of ischemia (<xref rid="bib0030" ref-type="bibr">Coyle, 1987</xref>) or epilepsy (<xref rid="bib0145" ref-type="bibr">L&#x000e9;vesque and Avoli, 2013</xref>). In recent years, neurodegeneration caused by systemic KA injection has been used to investigate mechanisms of the excitotoxic events (<xref rid="bib0295" ref-type="bibr">Sun and Chen, 1998</xref>, <xref rid="bib0035" ref-type="bibr">Dawson et al., 1995</xref>), and we also used KA to define the mechanisms of neurodegeneration and neuroprotection with PS (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>, <xref rid="bib0195" ref-type="bibr">Nabeka et al., 2015</xref>).</p><p id="par0045">Although the PS receptors have been defined as GPR37 and GPR37L1, orphan G protein- coupled receptors (<xref rid="bib0175" ref-type="bibr">Meyer et al., 2013</xref>), the movement of intrinsic PS in injured, as well as normal, nervous tissue remains unclear. We have shown that intrinsic PS and its mRNA increase in the facial nerve nucleus after nerve transection (<xref rid="bib0310" ref-type="bibr">Unuma et al., 2005</xref>, <xref rid="bib0010" ref-type="bibr">Chen et al., 2008</xref>) and decrease in the brain of mdx mice (<xref rid="bib0065" ref-type="bibr">Gao et al., 2013b</xref>), indicating its pivotal role in the survival of neurons and muscles.</p><p id="par0050">In the previous study, we have shown the increase of PS immunoreactivity and its mRNA expression in the hippocampal and cortical neurons on day 3 after KA injection, and high PS levels were maintained even after 3 weeks. The increase in PS, but not saposins, suggested that the increase in PS-like immunoreactivity after KA injection was not due to an increase in PS for lysosomal enzymes after neuronal damage, but rather in PS for a neurotrophic factor to improve neuronal survival (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>, <xref rid="bib0195" ref-type="bibr">Nabeka et al., 2015</xref>). The same study indicated that inhibitory interneurons as well as stimulated hippocampal pyramidal and cortical neurons synthesize PS for neuronal survival, and the choroid plexus is highly activated to synthesize PS, which may prevent neurons from excitotoxic neuronal damage (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>).</p><p id="par0055">In the present study, we aimed to clarify how PS act as a neurotrophic factor against exocitotoxic stimulation after systemic KA injection, for example which type of interneurons synthesize and transport PS, and whether up-regulated PS is secretion type or intracellular type.</p></sec><sec id="sec0010"><label>2</label><title>Materials And Methods</title><sec id="sec0015"><label>2.1</label><title>Animals</title><p id="par0060">Ten-week-old male Wistar rats (320&#x02013;350&#x000a0;g, total number&#x000a0;=&#x000a0;28) were used in this study. All animals were provided by CLEA-Japan (Kyoto) and housed at a constant temperature (22&#x000a0;&#x000b0;C) under a 12:12-h light: dark cycle and given food and water <italic>ad libitum</italic>. This study was carried out in strict accordance with the recommendations of the Guidelines of the Animal Care Committee of Ehime University. The protocol was approved by the Animal Care Committee of Ehime University (Permit Number: 05A261) All animal experimentation have been conducted in accordance with the Society's Policies on the Use of Animals and Humans in Research. All surgery was performed under chloral hydrate (10&#x000a0;mg/kg) anesthesia, and all efforts were made to minimize suffering.</p></sec><sec id="sec0020"><label>2.2</label><title>Antibodies</title><p id="par0065">Anti-PS IgG (0.1&#x000a0;&#x003bc;g/mL) was prepared by Medical and Biological Laboratories (Nakaku, Nagoya, Japan) (<xref rid="bib0285" ref-type="bibr">Shimokawa et al., 2013</xref>). From the amino acid sequence of rat PS (M19936; <xref rid="bib0025" ref-type="bibr">Collard et al., 1988</xref>), a synthetic oligopeptide corresponding to the proteolytic portion of PS (409- PKEPAPPKQPEEPKQSALRAHVPPQK-434), which did not encode saposins, was used to generate a rabbit polyclonal antibody against rat PS. So, this anti-PS IgG reacts with PS but not any of four saposins (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>).</p><p id="par0070">To determine which type of interneurons synthesized and secreted PS, we used immunofluorescence method with the combination of rabbit anti-PS IgG and mouse anti-GAD67 (gulitamic acid decarboxylase 67, 1:500, Millipore, Temecula, CA, USA), mouse anti-PV (parvalbumin, 1:500, Sigma, St. louis, MO, USA), mouse anti-CB, or mouse anti-CR (calbindin, 1:500, calretinin, 1:500, SWANT, Bellinzona, Switzerland) as the primary antibodies (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>, <xref rid="fig0010" ref-type="fig">Fig. 2</xref>, <xref rid="fig0015" ref-type="fig">Fig. 3</xref>, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>, <xref rid="fig0025" ref-type="fig">Fig. 5</xref>, <xref rid="fig0030" ref-type="fig">Fig. 6</xref>). As the second antibodies, we used Alexa Fluor 546 goat anti-rabbit IgG (H&#x000a0;+&#x000a0;L) (1:1000; Invitrogen, CA, USA) or Alexa Fluor 488 goat anti-mouse IgG (H&#x000a0;+&#x000a0;L) (1:1000; Invitrogen, CA, USA) and DAPI.<fig id="fig0005"><label>Fig. 1</label><caption><p>a-d: Crude hippocampal extracts from normal control and from animals 1or 3&#x000a0;days after kainic acid (KA) injection were examined using anti-PS, GAPDH, PV antibodies. When stained with anti-PS (a), the single band observed at&#x000a0;&#x0223c;&#x000a0;69&#x000a0;kDa, which likely corresponded to PS, significantly increased in intensity after KA treatment (d). When stained with anti-PV (c), the single band observed at&#x000a0;&#x0223c;&#x000a0;12&#x000a0;kDa, which likely corresponded to PV, significantly decreased in intensity after KA treatment (e). The intensities of the protein bands were quantified using the NIH Image software (b, d), and PS and PV protein levels were expressed as % of vehicle (mean&#x000a0;&#x000b1;&#x000a0;SD) normalized relative to GAPDH protein level. (*P&#x000a0;&#x0003c;&#x000a0;0.05, **P&#x000a0;&#x0003c;&#x000a0;0.01).</p></caption><alt-text id="at0005">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig><fig id="fig0010"><label>Fig. 2</label><caption><p>Immunofluorescence light micrographs of the hippocampal CA1 neurons stained with anti-PS IgG, anti-GAD, and DAPI showing the PS-IR 3&#x000a0;days after PBS (a) or 5&#x000a0;mg/kg KA (b) injection. The cell body and axon terminals of GABAergic interneurons in the CA1 region were stained green with an anti-GAD antibody (a, b). The arrows indicate interneurons with slender nuclei and very intense immunoreactivity both of PS and GAD in the cytoplasm. Note that the GAD-PS double positive axon terminals are observed around almost all CA1 neurons after KA injection (b), but only some ones (arrowheads) are observed in the CA1 after PBS injection (a). Nuclei are stained with DAPI (blue), PS is shown red, and GAD is shown green. The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0010">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig><fig id="fig0015"><label>Fig. 3</label><caption><p>Double immunofluorescence light micrographs of the rat hippocampal CA1 region 3&#x000a0;days after KA injection, stained with the antibody to PS and antibodies to GAD (a, b), PV (c, d), CB (e, f) or CR (g, h). Figures b, d, f and h are shown at a higher magnification of the CA1 pyramidal layers. PS are stained with anti-PS (red), cell bodies (indicated with arrows), axons and axon terminals of inhibitory neurons were stained with anti-GAD, PV, CB or CR (green), nuclei are stained with DAPI (blue), and merged. Note many putative axon terminals with strong PV &#x02212;IR around the pyramidal neurons (d). The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0015">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig><fig id="fig0020"><label>Fig. 4</label><caption><p>Immunofluorescence light micrographs of the hippocampus (a and b), CA1 (c&#x02013;f) and CA3 (g&#x02013;j) regions, and dentate gyrus (DG) (k and l) of rats 3&#x000a0;days after PBS injection (left column) or KA injection (right column) are shown. The sections were stained with anti-PS, anti-PV, and DAPI. In the overall images of the hippocampus (a and b), note the increase in PS, especially in the pyramidal neurons and CA3 mossy terminals (arrow), and the decrease in PV-positive neurons. A higher magnification of the pyramidal layers of CA1 (d and f) or CA3 (h and j) is shown. The nuclei are stained with DAPI (blue), PS is stained with anti-PS (red), and the cell bodies, axons, and axon terminals are stained with anti-PV (green) and merged. Arrowheads indicate the axon terminals, which are double-stained with PS and PV (yellow). Mol: st. moleculare, Rad: st. radiatum, Pyr: st. pyramidale, Ori: st. orience, L-Mol: st. lacunosum-moleculare, Luc: st. lucidum, Gran: st. granulare. The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0020">Fig. 4</alt-text><graphic xlink:href="gr4a"/><graphic xlink:href="gr4b"/></fig><fig id="fig0025"><label>Fig. 5</label><caption><p>Immunofluorescence light micrographs of PV-positive axons in the CA1, CA3 and DG regions of animals 3&#x000a0;days after PBS injection (left column) or KA injection (right column) stained with anti-PS, anti-PV and DAPI. Panels b, e, h, k, n and q are double positive axons intensely stained with anti-PS and anti-PV. Panels c, f, i, l, o and r are black-and-white images of the PS-IR (red) shown in b, e, h, k, n and q respectively, for the NIH Image analysis. Note that the PS-IR granules in the PV-positive axons in the KA-injected animals (l) are larger than those in the PBS injected ones (i). The ratio of PS-IR was significantly higher after KA injection compared with controls with PBS injection in CA1 (<sup>*</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) and CA3 (<italic>p</italic><sup>**</sup>&#x000a0;&#x0003c;&#x000a0;0.01). The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0025">Fig. 5</alt-text><graphic xlink:href="gr5"/></fig><fig id="fig0030"><label>Fig. 6</label><caption><p>Electron micrographs of pyramidal neurons and axons in the pyramidal layer of CA3 region with double-labeling of PS-IR (15&#x000a0;nm) with anti-saposin D antibody and PV-IR (5&#x000a0;nm) with anti-PV antibody. The PS-IR organelles seen in the rectangles in <xref rid="fig0030" ref-type="fig">Fig. 6</xref>a are shown at higher magnification in <xref rid="fig0030" ref-type="fig">Fig. 6</xref>b- e. PS-IR gold particles in three pyramidal neurons (PN) were observed in lysosome-like organelles (arrows in <xref rid="fig0030" ref-type="fig">Fig. 6</xref>c-e). On the other hand, PS-IR gold particles in the PV-IR axon were observed in the pale vesicles (arrows in <xref rid="fig0030" ref-type="fig">Fig. 6</xref>b), not resembling lysosome. PS like immunoreactivity (15&#x000a0;nm gold particles) stained with anti-saposin D antibody was observed in lysosome-like organelles (arrows) in the PV-positive (arrowheads) axon. The dotted lines express the borderlines of the PV-positive axon. Bars: The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0030">Fig. 6</alt-text><graphic xlink:href="gr6"/></fig></p><p id="par0075">To detect PS in the PV positive-axon terminals of interneurons, anti-sposin D antiserum was used for immuno-electron microscopy (<xref rid="fig0030" ref-type="fig">Fig. 6</xref>), because the above-mentioned anti-PS IgG dose not react with PS and only this anti-sposin D antiserum is usable and this antiserum was proven to show specific reaction to PS in the central nervous system (<xref rid="bib0115" ref-type="bibr">Hosoda et al., 2007</xref>).</p><p id="par0080">To detect axonal transport of PS, we used immunofluorescence method with the combination of Alexa fluor 594 conjugated rabbit anti-PS IgG and FITC conjugated rabbit anti-secretogranin II (Bioss Inc. Mass, USA) (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>). Immunofluorescence method with the combination of rabbit anti-PS IgG and mouse anti-synapsin IIa (BD Biosciences, USA) was also used (<xref rid="fig0040" ref-type="fig">Fig. 8</xref>).</p></sec><sec id="sec0025"><label>2.3</label><title>KA injection</title><p id="par0085">Rats (n&#x000a0;=&#x000a0;6 per group) were anesthetized with an intraperitoneal injection of diethylether and clonazepam (0.2&#x000a0;mg/kg) as an anticonvulsant. After 10&#x000a0;min, the rats were anesthetized again with diethylether, and KA dissolved in normal saline was injected subcutaneously (5&#x000a0;mg/kg). After KA injection, the animals were housed at a constant temperature (22&#x000a0;&#x000b0;C), as the effects of KA depend, at least in part, on body temperature (<xref rid="bib0190" ref-type="bibr">Nabeka et al. 2014</xref>). Under these conditions, no animal experienced status epilepticus, even with KA, and no clear damage was observed at the ordinal light-microscopic level (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>). Rats younger than 9 weeks that were injected with 5&#x000a0;mg/kg KA sometimes suffered some neuronal damage in the hippocampus, similar to observations in 10-week-old rats when injected with 8&#x000a0;mg/kg KA (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>).</p></sec><sec id="sec0030"><label>2.4</label><title>Analysis of PS, GAD, PV, CR, CB after KA injection using Western blot</title><p id="par0090">The rats were anesthetized and injected with clonazepam (0.2&#x000a0;mg/kg), followed by 5&#x000a0;mg/kg KA as mentioned above. Three days after KA or PBS injection, the hippocampi of the rats (n&#x000a0;=&#x000a0;6 per group) were dissected and homogenized in ice-cold 50&#x000a0;mM Tris-HCl (pH 6.8) buffer containing 0.1&#x000a0;M glycerol, 50&#x000a0;mM sodium dodecyl sulfate (SDS) and 4% protease inhibitor cocktail (Roche Diagnostics, Minatoku, Tokyo, Japan). The total protein extract was centrifuged at 12,000&#x000a0;&#x000d7;&#x000a0;g for 15&#x000a0;min at 4&#x000a0;&#x000b0;C, and the separated pellet was suspended in buffer in an equal volume as that of the supernatant. The solubilized proteins (50&#x000a0;&#x003bc;g) were separated by SDS-polyacrylamide gel electrophoresis (PAGE) on 10% polyacrylamide gels and transferred to a polyvinylidene difluoride membrane. The membrane was incubated with 5% BSA in TBS buffer (20&#x000a0;mM Tris-HCl, pH 7.4; 0.15&#x000a0;M NaCl) for 1&#x000a0;h at room temperature and then incubated with anti-saposin D serum (0.05&#x000a0;&#x003bc;g/mL) and anti-PS IgG (0.1&#x000a0;&#x003bc;g/mL) overnight at 4&#x000a0;&#x000b0;C. The membrane was then washed with TBS-T buffer (20&#x000a0;mM Tris-HCl, pH 7.4, 0.15&#x000a0;M NaCl, 1% Tween 20) and incubated with peroxidase-labeled anti-rabbit IgG (0.6&#x000a0;&#x003bc;g/mL; Dako, Glostrup, Denmark) for 1&#x000a0;h at room temperature, followed by treatment with the detection solution for enhanced chemiluminescence (ImmunoStar; Wako, Osaka, Japan). The immunoreactive protein bands were visualized using an LAS-4000 luminescence image analyzer (GE Healthcare Japan, Japan).</p></sec><sec id="sec0035"><label>2.5</label><title>Immunostaining of PS and GAD, PV, CR, CB</title><p id="par0095">Three days after KA or PBS injection, each animal was anesthetized by intraperitoneal injection of chloral hydrate (10&#x000a0;mg/kg) and perfused transcardially, first with 50-mL saline and then with 300-mL 4% paraformaldehyde in 0.1&#x000a0;M phosphate buffer. The brains were removed, cut into small pieces and post-fixed in the same solution for 4&#x000a0;h, and then embedded in paraffin using conventional methods, sectioned and deparaffinized. Following a brief rinse in PBS, the sections were exposed for 2&#x000a0;h to blocking solution containing 5% normal swine serum (NSS), 5% bovine serum albumin (BSA) and 0.25% carrageenan in PBS. The sections were processed for immunofluorescence with anti-PS antibody and anti-GAD, PV, CR, CB as the primary antibody at a 1:1,000 dilution.</p><p id="par0100">After washing with PBS, the sections were treated for 1&#x000a0;h at room temperature with Cy3-conjugated goat anti-rabbit IgG (1:500; Rockland, Gilbertsville, PA, USA) for detection of PS. Some sections were stained with rabbit anti-PS IgG and anti-GAD67 monoclonal antibody for GABA neurons, then treated with Cy3-conjugated goat anti-rabbit IgG (1:500; Rockland, Gilbertsville, PA, USA), Alexa Fluor 488 goat anti-mouse IgG (H&#x000a0;+&#x000a0;L) (1:1000; Life Technologies, Carlsbad, CA, USA) and DAPI. The sections were then washed with PBS, mounted in Mowiol (Calbiochem, San Diego, CA, USA) and examined using a Nikon A1 confocal microscope (Nikon, Tokyo, Japan) equipped with a 60&#x000a0;&#x000d7;&#x000a0;objective lens (Nikon) (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>, <xref rid="fig0015" ref-type="fig">Fig. 3</xref>, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>, <xref rid="fig0025" ref-type="fig">Fig. 5</xref>). The relative intensity of PS-IR signals in the hippocampal CA3 region was examined using computer-assisted image analysis as described below (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>).</p></sec><sec id="sec0040"><label>2.6</label><title>Immunoelectron microscopy of PS and PV</title><p id="par0105">Using the same anesthesia described above, the animals (n&#x000a0;=&#x000a0;2 per group) were perfused transcardially with saline followed by 300&#x000a0;ml of 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1&#x000a0;M phosphate buffer. The tissues were cut into thick sections at 50&#x000a0;&#x003bc;m; cryoprotected with 10, 20, and 30% glycerol in phosphate buffer; and quick-frozen in anhydrous ethanol precooled with dry ice. The centrifuge tubes containing the above sections in the 0.5% uranyl acetate solution precooled with dry ice were covered with more than 5&#x000a0;kg of conventional cooling materials in an adiabatic box precooled with dry ice, and the box was kept at &#x02212;80&#x000a0;&#x000b0;C for 24&#x000a0;h. The box was then moved to a freezer and kept at &#x02212;30&#x000a0;&#x000b0;C for 24&#x000a0;h. The thick sections were rinsed with anhydrous ethanol three times at &#x02212;30&#x000a0;&#x000b0;C; immersed in 30, 60, and 100% LR-White at &#x02212;30&#x000a0;&#x000b0;C for 1&#x000a0;hr, then kept for 1&#x000a0;h at 4&#x000a0;&#x000b0;C, and polymerized at 55&#x000a0;&#x000b0;C for 10&#x000a0;hr. Ultrathin sections were made with a diamond knife and were mounted on nickel grids and incubated in blocking solution containing 5% BSA, 10% NSS, 0.1% Triton X-100, and 0.1% sodium azide in PBS for 2&#x000a0;h. The sections were incubated in the blocking solution containing the rabbit anti-saposin D serum at dilution of 1:50 and the mouse anti-PV IgG at dilution of 1:50 at 4&#x000a0;&#x000b0;C overnight. After three rinses with the blocking solution, the section was incubated in the blocking solution containing two gold-conjugated Fab fragments (15&#x000a0;nm gold anti-rabbit and 5&#x000a0;nm gold anti-mouse) for 3&#x000a0;h. The section was rinsed with PBS, fixed in 1% glutaraldehyde in PBS for 10&#x000a0;min, rinsed with distilled water, double stained with uranyl acetate and lead citrate, and examined under a transmission electron microscope (H800; Hitachi, Tokyo, Japan).</p></sec><sec id="sec0045"><label>2.7</label><title>Analysis of PS mRNA after KA injection using in situ hybridization</title><p id="par0110">The probes for hybridization used in this study are listed in <xref rid="tbl0005" ref-type="table">Table 1</xref>. The rats were anesthetized and injected with clonazepam (0.2&#x000a0;mg/kg) followed by 5&#x000a0;mg/kg KA as described above. Three days after KA injection, the rats (n&#x000a0;=&#x000a0;6 per group) were decapitated, the forebrains were frozen on dry ice and cut into 20-&#x003bc;m frontal sections using a cryostat. <italic>In situ</italic> hybridization to detect PS mRNA was performed as described previously (<xref rid="bib0310" ref-type="bibr">Unuma et al., 2005</xref>, <xref rid="bib0275" ref-type="bibr">Sato and Tohyama, 1998</xref>, <xref rid="bib0150" ref-type="bibr">Li et al., 2013</xref>). Briefly, Three antisense 36-mer oligonucleotide probes (PS-AS1, PS-AS3 and PS-AS4) and one sense probe (PS-S1) were synthesized (<xref rid="tbl0005" ref-type="table">Table 1</xref>) commercially by Operon Biotechnologies (Tokyo, Japan). PS-AS3 and PS-AS4 are complementary to bases 834&#x02013;869 of NM_001190236 and bases 828&#x02013;863 of NM_013013, respectively. PS-AS1 is complementary to bases 1704&#x02013;1739 in the 3&#x02032;-untranslated region of prosaposin cDNA (M19936) and detects both Pro&#x000a0;+&#x000a0;0 mRNA and Pro&#x000a0;+&#x000a0;9 mRNA. The sense probe PS-S1, which is complementary to PS- AS1, was used as a control. The specificities of these 36-mer oligonucleotide probes have been demonstrated by dot-blot hybridization in the previous study (Saito et al., 2013). The frozen sections were fixed in 4% paraformaldehyde in 0.1&#x000a0;M PBS (pH 7.4) for 15&#x000a0;min, rinsed with 4&#x000d7; standard saline citrate (SSC; pH 7.4) and dehydrated using a graded ethanol series. The sections were then hybridized overnight at 41&#x000a0;&#x000b0;C with the <sup>35</sup>S-labeled antisense or sense probe at 1.0&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cpm/mL in hybridization buffer (50% formamide, 1% Denhardt&#x02019;s solution, 250&#x000a0;&#x003bc;g/mL tRNA, 0.1&#x000a0;g/mL dextran sulfate, 0.12&#x000a0;M PB, 0.02&#x000a0;mM/mL DTT in 4&#x000d7; SSC). After hybridization, the sections were rinsed three times with 1&#x000d7; SSC at 55&#x000a0;&#x000b0;C for 20&#x000a0;min, dehydrated using a graded ethanol series, coated with NBT2 emulsion (Eastman Kodak Company, Rochester, NY, USA) and exposed for 3 weeks at 4&#x000a0;&#x000b0;C. Finally, the sections were developed using a D-19 developer (Eastman Kodak) and observed under a light microscope (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>, <xref rid="fig0040" ref-type="fig">Fig. 8</xref>). The in situ hybridized hippocampal sections were counterstained with methyl green to visualize the nuclei (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>).<fig id="fig0035"><label>Fig. 7</label><caption><p>Double immunofluorescence light micrographs of the CA3 regions of rats 3&#x000a0;days after KA injection stained with anti-PS (red), anti-segretogranin (SG:green) and DAPI (blue). Many dot-like structures around pyramidal neurons were double-stained with PS and SG (yellow arrows). Some small dot-like structures in the neurons were also double-stained with PS and SG (yellow arrowheads) in the neuronal cytoplasm. Small dot-like structures stained only with PS were indicated with red arrowheads mainly in the cytoplasm (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>b) and those stained only with SG were indicated with green arrowheads (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>c). The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0035">Fig. 7</alt-text><graphic xlink:href="gr7"/></fig><fig id="fig0040"><label>Fig. 8</label><caption><p><bold>(a, b)</bold> I(a, b) Immunofluorescence light micrographs of rat CA3 regions 1&#x000a0;day after KA injection stained with anti-PS, anti-synapsin II, and DAPI. The PS immunostaining (red) is very strong in the strata pyramidale (Pyr) and lucidum (Luc), and synapsin II (green) is distributed in all areas, being particularly strong in the stratum lucidum (a). Many dot-like structures around pyramidal neurons in the strata pyramidale and lucidum were stained by both PS and synapsin II (yellow arrows in b) <bold>(c, d)</bold> Electron micrographs of the stratum lucidum in the CA3 region with double-labeling of PS-IR (15&#x000a0;nm) with anti-saposin D antibody and PV-IR (5&#x000a0;nm). In these micrographs, no PV-IR was observed. (c) PS-IR gold particles in lysosome-like organelles (arrows) were observed in the apical dendrite (AD) of pyramidal neurons and mossy fibers (MF) with many desomosome-like structures (red arrows), synaptic vesicles, and bundles of microtubules and neurofilaments. (d) PS-IR gold particles densely packed in small lysosome-like structures (arrows) were observed in the mossy terminal (MT) with many desomosome-like structures (red arrows). The numbers on the bar indicate &#x003bc;m..</p></caption><alt-text id="at0040">Fig. 8</alt-text><graphic xlink:href="gr8"/></fig><fig id="fig0045"><label>Fig. 9</label><caption><p><italic>In situ</italic> hybridization of the hippocampus showing PS mRNA in the rats 3&#x000a0;days after PBS injection (a, b) or KA injection (c, d, e). PS mRNA expression increased after KA injection compared with PBS injection in all areas. Pro&#x000a0;+&#x000a0;0 is more intense than Pro&#x000a0;+&#x000a0;9 both in KA and PBS injection. The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0045">Fig. 9</alt-text><graphic xlink:href="gr9"/></fig><table-wrap id="tbl0005" position="float"><label>Table 1</label><caption><p>Probes for hybridization.</p></caption><alt-text id="at0065">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Probe name</th><th align="left">Target</th><th align="left">Sequence</th></tr></thead><tbody><tr><td align="left">PS-AS1</td><td align="left">Pro&#x000a0;+&#x000a0;0, Pro&#x000a0;+&#x000a0;9</td><td align="left">5&#x02032;-TTCATTACCCTAGACCCACAAGTAGGCGACTTCTGC-3&#x02032;</td></tr><tr><td align="left">PS-AS3</td><td align="left">Pro&#x000a0;+&#x000a0;9</td><td align="left">5&#x02032;-CTTGGGTTGCTGATCCTGCATGTGCATCATCATCTG-3&#x02032;</td></tr><tr><td align="left">PS-AS4</td><td align="left">Pro&#x000a0;+&#x000a0;0</td><td align="left">5&#x02032;-TTCCTTGGGTTGCATGTGCATCATCATCTGGACGGC-3&#x02032;</td></tr><tr><td align="left">PS-S1</td><td align="left">Complementary to PS-AS1</td><td align="left">5&#x02032;-GCAGAAGTCGCCTACTTGTGGGTCTAGGGTAATAGAA-3&#x02032;</td></tr></tbody></table></table-wrap></p></sec><sec id="sec0050"><label>2.8</label><title>Statistical analysis</title><p id="par0115">The relative intensities of immunoreactivity in the immunoblot bands (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>) or immunohistochemistry (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>) and hybridization signals (<xref rid="fig0050" ref-type="fig">Fig. 10</xref>) in the hippocampus were blindly examined using computer-assisted image analysis. Briefly, digital images of the immunoblot bands and the central parts of CA1, CA3 and dentate gyrus (DG) were obtained using a Nikon A1 confocal microscope. The images were obtained under the same magnification and voltage in order to stabilize brightness. The average gray value of all pixels in each image (Figs. <xref rid="fig0005" ref-type="fig">1</xref>a, c, <xref rid="fig0025" ref-type="fig">5</xref>c, f, i, l, o, r, <xref rid="fig0050" ref-type="fig">10</xref>a&#x02013;e) was determined using NIH 1.56 software (public domain software by Dr. Steve Barrett). Then the ratio of the gray values obtained from the image was calculated. The statistical significance of the ratios was examined by one-way analysis of variance (ANOVA) and <italic>post hoc</italic> Fisher&#x02019;s PLSD tests using the program StatView (Abacus Concepts Inc., Berkeley, CA, USA).<fig id="fig0050"><label>Fig. 10</label><caption><p>Comparison of PS mRNA signals in the hippocampal CA3 and choroid plexus (CP) in rats 3&#x000a0;days after KA or PBS injection. Relative density of AS4 (Pro&#x000a0;+&#x000a0;0) PS mRNA, semi-quantified using NIH Image software, with background intensity subtracted, significantly increased both in CA3 and CP after KA injection compared with the PBS-injected control (n&#x000a0;=&#x000a0;6); intensities are presented as means&#x000a0;&#x000b1;&#x000a0;standard error (S.E.) (*P&#x000a0;&#x0003c;&#x000a0;0.05, **P&#x000a0;&#x0003c;&#x000a0;0.01). The numbers on the bar indicate &#x003bc;m.</p></caption><alt-text id="at0050">Fig. 10</alt-text><graphic xlink:href="gr10"/></fig></p></sec></sec><sec id="sec0055"><label>3</label><title>Results</title><sec id="sec0060"><label>3.1</label><title>Western blotting (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>)</title><p id="par0120">Immunoblotting of the hippocampus using antibody against PS showed only one band at approximately 69&#x000a0;kDa and a clear increase in PS after KA injection (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>a, b), but there was no saposin band that was reported in the spleen and other tissues (<xref rid="bib0260" ref-type="bibr">Sano et al., 1989</xref>, <xref rid="bib0285" ref-type="bibr">Shimokawa et al., 2013</xref>).</p><p id="par0125">Immunoblotting of the hippocampus using antibodies against PV showed a clear decrease after KA injection (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>c, d). This decrease in PV indicates the exhaustion of PV after KA injection.</p><p id="par0130">Immunofluorescence staining of PS and GAD (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>)</p><p id="par0135">To clarify which types of cells strongly express PS after KA injection, the colocalization of PS and GAD was examined by double immunostaining of the hippocampus 3&#x000a0;days after KA injection. The intensities of PS and GAD immunoreactivity (IR) in the interneurons increased, and were more intense overall than in the CA1 Pyramidal neurons (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>a, b). Besides the cell bodies of interneurons, PS and GAD double-IR axon terminals around pyramidal neurons were observed, and they were more numerous after the injection of KA (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>b) than PBS (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>a).</p></sec><sec id="sec0065"><label>3.2</label><title>Change of GAD, PV, CB, CR immunoreactivity after KA injection (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>)</title><p id="par0140">To determine which types of subpopulation of GABAergi neuron strongly express PS after KA injection, the colocalization of PS and GAD, PV, CB or CR was examined by double immunofluorescence staining of the hippocampus 3&#x000a0;days after KA injection (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>). The intensity of PS-IR in the PV positive interneuron was the strongest in these GABAergic markers (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>c), especially in the PV positive axonal terminals around the pyramidal neurons were extremely strong (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>d) compared with CB (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>f) and CR (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>h).</p></sec><sec id="sec0070"><label>3.3</label><title>Change of PS and PV immunoreactivity after KA injection (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, <xref rid="fig0025" ref-type="fig">Fig. 5</xref>)</title><p id="par0145">In low-power micrographs of the hippocampus, the number of PV-positive neurons decreased after KA injection compared with PBS injection (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, a and b). However, the intensity of PS-IR in axons around pyramidal neurons was much higher after KA injection than PBS injection in all areas. In particular, the number of PS and PV double positive axon terminals around the CA1 and CA3 pyramidal neurons was much higher after KA injection (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, f and j) than PBS injection (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, d and h). With the exception of the basal portion of the molecular layer, the number of PS and PV double positive axon terminals around DG granular neurons was low (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, k and l). The diameter of PS-positive immunofluorescent reactions was 0.3&#x02013;1.0&#x000a0;&#x003bc;m (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>, c, f, i, and l).</p><p id="par0150">For morphometrical analysis of the difference in axonal PS-IR between KA and PBS injection, the red fluorescence of PS-IR (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>b, e, h, k, n, q) was changed to a black-and-white image (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>c, f, I, l, o, r), and the intensity was analyzed using NIH 1.56 software (public domain software by Dr. Steve Barrett)(<xref rid="fig0025" ref-type="fig">Fig. 5</xref>s, t, u). The PS-IR in the axons around the CA1 and CA3 pyramidal neurons were significantly increased after KA injection compared with PBS injection (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>s, t), but PS-IR in the axons around the granular neurons in the DG increased moderately (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>u). Compared with CA1, a greater increase in PS-IR was observed in CA3 (Figs. <xref rid="fig0020" ref-type="fig">4</xref>a&#x02013;h, <xref rid="fig0025" ref-type="fig">5</xref>).</p></sec><sec id="sec0075"><label>3.4</label><title>PS immunoreactivity in the PV positive axon terminals with electron microscopy (<xref rid="fig0030" ref-type="fig">Fig. 6</xref>, <xref rid="fig0040" ref-type="fig">Fig. 8</xref>)</title><p id="par0155">Electron micrographs of the pyramidal layer of CA3 region stained with anti-saposin D and anti-PV showed that saposin D-IR gold particles in the pyramidal neurons (PN) were localized in lysosome-like organelles (arrows in <xref rid="fig0030" ref-type="fig">Fig. 6</xref>c&#x02013;e) as reported before (<xref rid="bib0115" ref-type="bibr">Hosoda et al., 2007</xref>). On the other hand, saposin D &#x02212;IR gold particles in the PV-IR axon were observed in the pale vesicles (arrows in <xref rid="fig0030" ref-type="fig">Fig. 6</xref>b), not resembling lysosome. The diameter of these saposin D &#x02212;IR vesicles was about 0.1&#x02013;0.4&#x000a0;&#x003bc;m</p></sec><sec id="sec0080"><label>3.5</label><title>PS immunoreactivity colocarized with segretogranin (SG) or synapsin (SS) (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>, <xref rid="fig0040" ref-type="fig">Fig. 8</xref>)</title><p id="par0160">Double immunofluorescence light micrographs with anti-PS, anti-SG and DAPI showed that many dot-like structures around pyramidal neurons were double-stained with PS and SG (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>). Some small dot-like structures double-stained with PS and SG were also observed in the neuronal cytoplasm. Small dot-like structures stained only with PS were observed mainly in the cytoplasm (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>b) and those single-stained with SG were also observed (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>c).</p><p id="par0165">Double immunofluorescence light micrographs of the CA3 regions of the animal 1&#x000a0;day after PBS injection stained with anti-PS, anti-synapsin II and DAPI showed that many dot-like structures around pyramidal neurons were double-stained with PS and synapsin II (<xref rid="fig0040" ref-type="fig">Fig. 8</xref>). The immunostaining of PS is strong in the strata pyramidale and lucidum, and that of synapsin II is very strong in stratum lucidum (<xref rid="fig0040" ref-type="fig">Fig. 8</xref>a). Many dot-like structures around pyramidal neurons in the strata pyramidale and lucidum were stained both with PS and synapsin II (<xref rid="fig0040" ref-type="fig">Fig. 8</xref>b).</p><p id="par0170">Electron micrographs of the stratum lucidum in the CA3 region, in the same section as in <xref rid="fig0030" ref-type="fig">Fig. 6</xref>, showed PS-IR gold particles in lysosome-like organelles in the apical dendrites of pyramidal neurons and mossy fibers (<xref rid="fig0040" ref-type="fig">Fig. 8</xref>c). PS-IR gold particles densely packed in small lysosome-like structures were observed in the mossy terminal with many desomosome-like structures (<xref rid="fig0040" ref-type="fig">Fig. 8</xref>d).</p></sec><sec id="sec0085"><label>3.6</label><title>Expression of PS mRNA after KA injection (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>, <xref rid="fig0050" ref-type="fig">Fig. 10</xref>, <xref rid="fig0055" ref-type="fig">Fig. 11</xref>)</title><p id="par0175">In situ hybridization was performed in the adult rat brain with the following probes: PS-AS4 for Pro&#x000a0;+&#x000a0;0 mRNA, PS-AS3 for Pro&#x000a0;+&#x000a0;9 mRNA, PS-AS1 for both Pro&#x000a0;+&#x000a0;0 and Pro&#x000a0;+&#x000a0;9 mRNAs and the sense probe PS-S1 for the sequence complementary to PS-AS1 (<xref rid="bib0115" ref-type="bibr">Hosoda et al., 2007</xref>, <xref rid="bib0010" ref-type="bibr">Chen et al., 2008</xref>, <xref rid="bib0320" ref-type="bibr">Xue et al., 2011</xref>, <xref rid="bib0150" ref-type="bibr">Li et al., 2013</xref>, <xref rid="bib0285" ref-type="bibr">Shimokawa et al., 2013</xref>, <xref rid="bib0250" ref-type="bibr">Saito et al., 2014</xref>).</p><p id="par0180">In the PBS-injected control animals, weak hybridization signals of PS-AS3 (Pro&#x000a0;+&#x000a0;9) were observed in the neuronal cell layers of hippocampal CA1, CA2, CA3, CA4, DG, choroid plexus and cerebral cortex (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>a1-6). Similar hybridization signals of PS-AS4 (Pro&#x000a0;+&#x000a0;0) were observed in the neuronal cell layers of hippocampal CA1, CA2, CA3, CA4, DG and cerebral cortex (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>b1-4, b6), except for the choroid plexus where strong signals were observed (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>b5).</p><p id="par0185">In the KA-injected animals, weak hybridization signals of PS-AS3 (Pro&#x000a0;+&#x000a0;9) were similar in all areas of the PBS-injected animals (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>c1-6). In contrast, strong hybridization signals of PS-AS4 (Pro&#x000a0;+&#x000a0;0) were observed in the neuronal cells of all areas (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>d1-4, b6), and very strong signals were observed in the choroid plexus (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>d5). The control sections stained with sense oligonucleotide probe (PS-S1) showed only faint hybridization signals in all areas (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>e1-6).</p><p id="par0190">morphometrical analysis of the difference in hybridization signals (<xref rid="fig0050" ref-type="fig">Fig. 10</xref>)</p><p id="par0195">For morphometrical analysis of the difference in hybridization signals between PS-AS3, PS-AS4, PS-S1 after KA or PBS injection, the photomicrographs were taken in the same condition of microscope illumination (<xref rid="fig0050" ref-type="fig">Fig. 10</xref>a-e), and their intensities were analyzed using NIH 1.56 software (<xref rid="fig0050" ref-type="fig">Fig. 10</xref>f). The hybridization signals of PS-AS4 in the all areas and choroid plexus were significantly increased after KA injection compared with PBS injection (<xref rid="fig0050" ref-type="fig">Fig. 10</xref>f, g).</p></sec><sec id="sec0090"><label>3.7</label><title>Expression of PS mRNA observed in the higher magnification after nuclear counterstaining (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>)</title><p id="par0200">The sections of <italic>in situ</italic> hybridization were counterstained with methyl green to visualize the nuclei as well as the hybridization signals (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>). The signals of AS4 were much stronger than those of AS3 in the all areas of the hippocampus, cerebral cortex and choroid plexus (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>), especially in the CA3 (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>d) and the choroid plexus (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>l).<fig id="fig0055"><label>Fig. 11</label><caption><p><italic>In situ</italic> hybridization of the hippocampus showing PS mRNA expression at higher magnification. The hybridization signals are shown as tiny black dots, and the nuclei were stained bluish green with methyl green. The section stained with probe Pro&#x000a0;+&#x000a0;9 showed only faint hybridization signals (left column), but the Pro&#x000a0;+&#x000a0;0 signals (right column) in all hippocampal areas and choroid plexus (CP) were very intense. Red arrows indicate the intense interneurons in the extra-Pyr layer in CA3 region (d), yellow arrow indicates the interneuron in the intra-Pyr layer with slender nuclei, and green arrows indicate smaller glial nuclei without signal. The numbers on the bar indicates &#x003bc;m.</p></caption><alt-text id="at0055">Fig. 11</alt-text><graphic xlink:href="gr11"/></fig></p><p id="par0205">In the higher magnification, the signals of each cell show a wide variety of intensity in the CA3 (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>c, d), CA4 (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>e, f), and the cerebral cortex (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>e, f), but rather even in the CA1 (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>a, b) and DG (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>g, h). The strong signals in the CA3 region were localized mainly in the pyramidal layer, but some strong signals were observed outside of the pyramidal layer, such as in the strata radiatum and lacunosum-moleculare or the upper portion of the stratum oriens (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>d). Based on their localization, size and form of nuclei, these cells appeared to be interneurons and not glial cells. These cells were observed mainly in the CA3 area (<xref rid="fig0050" ref-type="fig">Fig. 10</xref>c, d), but a few in the CA1 area (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>a, b).</p></sec></sec><sec id="sec0095"><label>4</label><title>Discussion</title><p id="par0210">In our previous study, we found the increase of PS mRNA level in the rat hippocampus and the choroid plexus after KA-induced brain injury, leading the notion that increased PS may contribute the prevention of apoptosis in the damaged neurons (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>). In fact, a synthetic peptide corresponding to the neurotrophic activity region of PS prevented the KA-induced neurodegeneration (<xref rid="bib0195" ref-type="bibr">Nabeka et al., 2015</xref>). The increase of PS expression level also has been reported in the CNS after the sciatic nerve injury (<xref rid="bib0075" ref-type="bibr">Gillen et al., 1995</xref>), the transient forebrain ischemia (<xref rid="bib0325" ref-type="bibr">Yokota et al., 2001</xref>, <xref rid="bib0100" ref-type="bibr">Hiraiwa et al., 2003</xref>), the cortical stab wound injury (<xref rid="bib0100" ref-type="bibr">Hiraiwa et al., 2003</xref>), and the facial nerve transection (<xref rid="bib0010" ref-type="bibr">Chen et al., 2008</xref>). These studies indicate PS plays an important role in the healing process of the injured nervous system. In the present study, the higher increase of PS in CA3 compared with CA1 is most likely because the concentration of KA receptors is highest in CA3 (<xref rid="bib0170" ref-type="bibr">Malva et al., 1998</xref>, <xref rid="bib0315" ref-type="bibr">Wang et al., 2005</xref>).</p><p id="par0215">Several alternatively spliced mRNAs are found for PS gene (<xref rid="bib0100" ref-type="bibr">Hiraiwa et al., 2003</xref>). Main two forms of them are the mRNA with or without 9-base insertion (Pro&#x000a0;+&#x000a0;9 and Pro&#x000a0;+&#x000a0;0 mRNA). <xref rid="bib0100" ref-type="bibr">Hiraiwa et al. (2003)</xref> reported that the expression ratio of Pro&#x000a0;+&#x000a0;9 and Pro&#x000a0;+&#x000a0;0 mRNA changes from 85:15 to 5:95 in the rat brain after experimental brain ischemia or cortical stab wound injury. <xref rid="bib0010" ref-type="bibr">Chen et al. (2008)</xref> also showed significant increase of Pro&#x000a0;+&#x000a0;0 mRNA expression in the facial nerve nucleus after the facial nerve transection. In the present study, significant increase of Pro&#x000a0;+&#x000a0;0 mRNA expression also has been observed not only in the pyramidal excitatory neuron but also in the inhibitory interneuron in the rat hippocampus after KA injection. These findings may indicate the transcript of Pro&#x000a0;+&#x000a0;0 mRNA assumes the neurotrophic function in the healing process of the injured nervous system.</p><p id="par0220">On the other hand, Pro&#x000a0;+&#x000a0;9 mRNA is reportedly expressed preferentially in tissues in which the intact form of PS dominates, whereas Pro&#x000a0;+&#x000a0;0 mRNA is preferentially expressed in tissues in which the precursor dominates. Because the choroid plexus is responsible for the generation of cerebrospinal fluid containing the intact form of PS, the increase of Pro&#x000a0;+&#x000a0;9 mRNA should be expected. But actually, clear increase in the neurons and choroid plexus after KA injection was Pro&#x000a0;+&#x000a0;0 mRNA (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>d). Also in the previous study, we suggested that Pro&#x000a0;+&#x000a0;0 mRNA is related to the intact form in the choroid plexus, and that the alternatively spliced forms of mRNAs do not simply correspond to the precursor and intact forms of PS (Saito et al., 2013).</p><p id="par0225">Although the neurotrophic activity region was found in saposin C domain of PS, the alternative splicing occurred in its saposin B domain (<xref rid="bib0105" ref-type="bibr">Holtschmidt et al., 1991a</xref>, <xref rid="bib0110" ref-type="bibr">Holtschmidt et al., 1991b</xref>). At present it is unclear for the neurotrophic function of the splicing region in injured nervous system. Interestingly, the choroid plexus generates the cerebrospinal fluid containing considerable amount of intact form PS (<xref rid="bib0090" ref-type="bibr">Hineno et al., 1991</xref>), and expresses Pro&#x000a0;+&#x000a0;0 mRNA intensely but Pro&#x000a0;+&#x000a0;9 mRNA weakly (<xref rid="bib0250" ref-type="bibr">Saito et al., 2014</xref>). In addition, the expression of Pro&#x000a0;+&#x000a0;0 mRNA was found to increase in the choroid plexus on KA-induced brain injury in this study. Therefore, there is a possibility that Pro&#x000a0;+&#x000a0;0 mRNA expression is convenient for synthesis and secretion of intact form PS in the nervous system. The increase of Pro&#x000a0;+&#x000a0;0 mRNA in the inhibitory interneuron after KA injection and PS-containing vesicles in the axon terminals of the interneuron, and the report that the interneuron may promote the survival of the pyramidal neuron by secreting the inhibitory neurotransmitter (<xref rid="bib0155" ref-type="bibr">Liang et al., 2009</xref>) lead us notion that PS is also one of the secreting factor from the interneuron around the pyramidal neuron for their survival in the injured hippocampus (<xref rid="fig0060" ref-type="fig">Fig. 12</xref>).<fig id="fig0060"><label>Fig. 12</label><caption><p>Schematic presentation of the neuroprotection against exocitotoxic stimulation. The pyramidal neurons can produce neuroprotective PS and use it paracrine or autocrine manner. Parvalbumin (PV) positive interneurons around pyramidal layer can produce PS, transport it to the axon terminals and secrete it with GABA around the pyramidal neurons. The choroid plexus also produce and secrete PS to the cerebrospinal fluid react to the exocitotoxic stimulation of kainic acid.</p></caption><alt-text id="at0060">Fig. 12</alt-text><graphic xlink:href="gr12"/></fig></p><p id="par0230">In the present study, we also aimed to clarify which interneuron was up-regulated to produce PS and how PS function after systemic KA injection. <xref rid="bib0055" ref-type="bibr">Freund and Buzs&#x000e1;ki (1996)</xref> proposed that the term hippocampal &#x0201c;interneuron&#x0201d; should be synonymous with &#x0201c;GABAergic with no principal cell&#x0201d;. In the present study, interneurons outside of the pyramidal layer were easily defined, and those inside the pyramidal layer were defined as slender cell bodies and nuclei (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>d). Our previous results showed that PS mRNA signals in the interneurons increased abruptly 1&#x000a0;day after KA injection, and those of PS-IR increased after 1&#x000a0;day and peaked 3&#x000a0;days after KA injection (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>). These results indicate that KA injection stimulated the interneurons to produce PS more strongly than the pyramidal neurons.</p><p id="par0235">PV-positive interneurons account for approximately half of the GABAergic neurons in the hippocampus. Axon terminals fields immunoreactive for PV are extremely dense in the cell body layers and proximal stratum oriens. The majority of PV-positive varicosities surround the cell bodies and axon initial segments of principal neurons. This characteristic laminar distribution of PV-positive axon terminal fields overlaps with that of basket and axo-axonic (chandelier) neurons, suggesting that these morphologically identified neuron types selectively contain PV (<xref rid="bib0055" ref-type="bibr">Freund and Buzs&#x000e1;ki, 1996</xref>). In a recent in-vivo study, intracellularly recorded and labeled basket neurons were shown to be immunoreactive for PV but not for CB or CR (<xref rid="bib0245" ref-type="bibr">S&#x000ed;k et al., 1995</xref>). In the present study, the majority of PV-positive bouton-like structures contain PS-IR (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, <xref rid="fig0025" ref-type="fig">Fig. 5</xref>).</p><p id="par0240">The increase in PV-IR in the axon seems to contradict with the results in <xref rid="fig0005" ref-type="fig">Fig. 1</xref>, which shows a significant reduction in the level of PV protein (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>, c and e). However, the number of PV-IR neurons in the hippocampus decreased (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, a and b). This reduction in PV-positive neurons may have caused the reduction of total PV content in the hippocampus. Decreased PV expression was also reported in PV-positive GABAergic interneurons in schizophrenia (<xref rid="bib0080" ref-type="bibr">Hashimoto et al., 2003</xref>, <xref rid="bib0210" ref-type="bibr">Nakazawa et al., 2012</xref>). PV reduction may be related to some pathological states. A reduction in PV in neuronal cell bodies and an increase in PV in axons may indicate the movement of PV from neuronal bodies to axons in pathological conditions.</p><p id="par0245"><xref rid="bib0155" ref-type="bibr">Liang et al. (2009)</xref> reported that the amplitudes of evoked inhibitory postsynaptic currents were increased significantly 12&#x000a0;h after ischemia and then returned to control levels 24&#x000a0;h following reperfusion with voltage clamp recording. They suggested that this transient enhancement of inhibitory neurotransmission might temporarily protect CA1 pyramidal neurons and delay neuronal death after cerebral ischemia. Therefore, transient enhancement of inhibitory neurons might protect pyramidal neurons by inhibitory currents (<xref rid="fig0060" ref-type="fig">Fig. 12</xref>). Similarly, PS released from the axonal terminals of interneurons around the pyramidal neurons also might protect the pyramidal neurons (<xref rid="fig0060" ref-type="fig">Fig. 12</xref>). Accordingly, the PS-IR in the bouton-like structures around the pyramidal neurons was strongly increased after KA injection (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>j-l).</p><p id="par0250">PS mRNA expression in the choroid plexus of normal control animals was strong (<xref rid="fig0040" ref-type="fig">Fig. 8</xref>b5), as reported previously (<xref rid="bib0250" ref-type="bibr">Saito et al., 2014</xref>). This observation is reinforced by the report that cerebrospinal fluid in normal animals contains a significant amount of PS (<xref rid="bib0090" ref-type="bibr">Hineno et al., 1991</xref>). Furthermore, 3&#x000a0;days after KA injection, the hybridization signal in the choroid plexus was very strong (<xref rid="fig0045" ref-type="fig">Fig. 9</xref>d5). These results indicate that a lot of PS is produced in the choroid plexus and secreted into the cerebrospinal fluid after some direct or indirect KA stimulations to the choroid plexus (<xref rid="fig0060" ref-type="fig">Fig. 12</xref>).</p><p id="par0255">In conclusion, as <xref rid="fig0060" ref-type="fig">Fig. 12</xref> indicates, PV-positive inhibitory interneurons are the main neurons helping the pyramidal neurons from the exocitotoxic stimulation of kainic acid or other similar phenomenon caused by ischemia. Pyramidal neurons receive synaptic input, delivering inhibitory neurotransmitter (GABA) and neurotrofic factor (PS) that sustain neuronal survival (<xref rid="fig0060" ref-type="fig">Fig. 12</xref>).</p><p id="par0260">Neurotrophins, a family of secretory neurotrophic factors including NGF, BDNF, NT-3, NT-4/5, are famous to promote neuronal survival and differentiation. PS is also identified as a neurotrophins (<xref rid="bib0225" ref-type="bibr">O'Brien et al., 1994</xref>, <xref rid="bib0290" ref-type="bibr">Sorice et al., 2008</xref>). Neurotrophins, particularly BDNF, could elicit rapid and acute regulation of synaptic transmission and plasticity in the central nervous system (<xref rid="bib0165" ref-type="bibr">Lou et al., 2005</xref>). BDNF, NT-3 and PS have been reported to rerate with sortilin that controls intracellular sorting of BDNF (<xref rid="bib0020" ref-type="bibr">Chen et al., 2005</xref>) and PS (<xref rid="bib0330" ref-type="bibr">Yuan and Morales, 2011</xref>) to the regulated secretory pathway. Activity-dependent secretion of BDNF has been reported in many neuronal populations (See <xref rid="bib0165" ref-type="bibr">Lou et al., 2005</xref>), and its physiological significance has been highlighted by a number of recent studies (<xref rid="bib0015" ref-type="bibr">Chen et al., 2004</xref>, <xref rid="bib0040" ref-type="bibr">Egan et al., 2003</xref>). Taken together, it is not the infeasible idea that PS is also secreted in an activity-dependent manner especially after kainic acid neurotoxic stimulation.</p><p id="par0265">Although, the mechanism of PS secretion is not clear, a possible mechanism of intracellular Ca<sup>2+</sup>-dependent secretion is suggestive as the BDNF secretion reported in literature. Ca<sup>2+</sup> influx through NMDA receptor/L-type VGCC and subsequent Ca<sup>2+</sup> release of internal stores via ryanodine receptors are required for secretion. CaMKII, PKA, synaptotagmin IV, and CAPS2 also critically contribute to the membrane fusion process of BDNF-containing vesicles (<xref rid="bib0005" ref-type="bibr">Adachi et al., 2014</xref>). Further experiments about the change of these factors after kainic acid may clarify the mechanism of PS secretion.</p><p id="par0270">Anti-PS IgG used in the present study was prepared to a synthetic oligopeptide corresponding to the proteolytic portion between saposin C and D, and reacts with PS but not with any of four saposins (<xref rid="bib0190" ref-type="bibr">Nabeka et al., 2014</xref>). The major proteolytic pathway of PS has been reported to begin with cleavage of saposin A from PS and progress from B-C-D trisaposin to B-C or C-D disaposins and finally to monosaposin (<xref rid="bib0235" ref-type="bibr">Qi and Grabowski, 2001</xref>). Our anti-PS IgG can react with B-C-D trisaposin, or C-D disaposin, but immunoblot analysis showed no band for these proteins (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>). Also in the immunoblot of nervous tissues with anti-saposin D or anti-saposin B, the bands of trisaposin or disapsin were not observed but a faint band of saposin D was observed (<xref rid="bib0115" ref-type="bibr">Hosoda et al., 2007</xref>). These results indicate that PS works mainly with no or a few participation of proteolytic pathway in the nervous tissues.</p><p id="par0275">Electron micrographs of the pyramidal layer of CA3 region stained with anti-saposin D and anti-PV showed PS-IR gold particles in the pale vesicles in the PV-IR axon. These vesicles were pale not resembling lysosome (<xref rid="fig0030" ref-type="fig">Fig. 6</xref>b). On the other hand, the vesicles in the pyramidal neurons without PV-IR were dark, resembling ordinal lysosomes (<xref rid="fig0030" ref-type="fig">Fig. 6</xref>c-e) as shown before (<xref rid="bib0115" ref-type="bibr">Hosoda et al., 2007</xref>). Unfortunately, as the specific antibody to PS could not react well with PS in the electron microscopy, we used anti-saposin D antibody that reacts both of PS and saposin-D. However, increased PS in PV positive axon-like structures was shown under a light microscope with specific antibodies to PS (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>, <xref rid="fig0025" ref-type="fig">Fig. 5</xref>). We believe that the gold particles in the pale vesicles in PV-IR axons are PS (<xref rid="fig0030" ref-type="fig">Fig. 6</xref>b).</p><p id="par0280">Secretogranins (SG) is a protein stored in secretory granules of endocrine cells (<xref rid="bib0240" ref-type="bibr">Rosa et al., 1985</xref>) and in large dense cored vesicles (LDCV) of neurons and neuroendocrine cells, and SG is thought to participate in the sorting and packaging of peptide hormones and neuropeptides into secretory granules (see <xref rid="bib0185" ref-type="bibr">Miyazaki et al., 2011</xref>). <xref rid="bib0185" ref-type="bibr">Miyazaki et al. (2011)</xref> showed that strong SG immunoreactivity was seen in PV-positive interneurons and nerve terminals, and suggested its role in the sorting and packaging of molecules other than neuropeptides in non-LDCV compartments. In the present study, SG was observed mainly in the putative axons or axonal terminal of interneurons around the pyramidal neurons in the hippocampal CA3 region (<xref rid="fig0035" ref-type="fig">Fig. 7</xref>b, c), and SG thought to participate in the sorting and packaging of PS.</p><p id="par0285">Recently, <xref rid="bib0175" ref-type="bibr">Meyer et al. (2013)</xref> identified GPR37 and GPR37L1, orphan G-protein-coupled receptors, as PS receptors. Following secretion, PS can undergo endocytosis via an interaction with the low-density lipoprotein- related receptor 1 (LRP1). The ability of secreted PS to promote protective effects in the nervous system is known to involve activation of G proteins, and the orphan G protein- coupled receptors GPR37 and GPR37L1 have recently been shown to mediate signaling induced by both PS and a fragment of PS known as prosaptide (see review of <xref rid="bib0180" ref-type="bibr">Meyer et al. 2014</xref>). Future studies should reveal whether a difference in the two saposin B isoforms of PS affects its affinity to these receptors.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>N.</given-names></name><name><surname>Numakawa</surname><given-names>T.</given-names></name><name><surname>Richards</surname><given-names>M.</given-names></name><name><surname>Nakajima</surname><given-names>S.</given-names></name><name><surname>Kunugi</surname><given-names>H.</given-names></name></person-group><article-title>New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases</article-title><source>World J. Biol. Chem.</source><volume>5</volume><year>2014</year><fpage>409</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">25426265</pub-id></element-citation></ref><ref id="bib0010"><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name><name><surname>Terashita</surname><given-names>T.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Mominoki</surname><given-names>K.</given-names></name><name><surname>Miyawaki</surname><given-names>K.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Expression patterns in alternative splicing forms of prosaposin mRNA in the rat facial nerve nucleus after facial nerve transection</article-title><source>Neurosci. Res.</source><volume>60</volume><year>2008</year><fpage>82</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">18022721</pub-id></element-citation></ref><ref id="bib0015"><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.Y.</given-names></name><name><surname>Patel</surname><given-names>P.D.</given-names></name><name><surname>Sant</surname><given-names>G.</given-names></name><name><surname>Meng</surname><given-names>C.X.</given-names></name><name><surname>Teng</surname><given-names>K.K.</given-names></name><name><surname>Hempstead</surname><given-names>B.L.</given-names></name><name><surname>Lee</surname><given-names>F.S.</given-names></name></person-group><article-title>Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons</article-title><source>J. Neurosci.</source><volume>24</volume><year>2004</year><fpage>4401</fpage><lpage>4411</lpage><pub-id pub-id-type="pmid">15128854</pub-id></element-citation></ref><ref id="bib0020"><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.Y.</given-names></name><name><surname>Ieraci</surname><given-names>A.</given-names></name><name><surname>Teng</surname><given-names>H.</given-names></name><name><surname>Dall</surname><given-names>H.</given-names></name><name><surname>Meng</surname><given-names>C.X.</given-names></name><name><surname>Herrera</surname><given-names>D.G.</given-names></name><name><surname>Nykjaer</surname><given-names>A.</given-names></name><name><surname>Hempstead</surname><given-names>B.L.</given-names></name><name><surname>Lee</surname><given-names>F.S.</given-names></name></person-group><article-title>Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway</article-title><source>J. Neurosci.</source><volume>25</volume><year>2005</year><fpage>6156</fpage><lpage>6166</lpage><pub-id pub-id-type="pmid">15987945</pub-id></element-citation></ref><ref id="bib0025"><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Collard</surname><given-names>M.W.</given-names></name><name><surname>Sylvester</surname><given-names>S.R.</given-names></name><name><surname>Tsuruta</surname><given-names>J.K.</given-names></name><name><surname>Griswold</surname><given-names>M.D.</given-names></name></person-group><article-title>Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat sertoli cells: sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator</article-title><source>Biochemestry</source><volume>27</volume><year>1988</year><fpage>4557</fpage><lpage>4564</lpage></element-citation></ref><ref id="bib0030"><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Coyle</surname><given-names>J.T.</given-names></name></person-group><article-title>Kainic acid: insights into excitatory mechanisms causing selective neuronal degeneration</article-title><source>Ciba Found Symposium.</source><volume>126</volume><year>1987</year><fpage>186</fpage><lpage>203</lpage></element-citation></ref><ref id="bib0035"><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>R.</given-names><suffix>Jr.</suffix></name><name><surname>Beal</surname><given-names>M.F.</given-names></name><name><surname>Bondy</surname><given-names>S.C.</given-names></name><name><surname>Di Monte</surname><given-names>D.A.</given-names></name><name><surname>Isom</surname><given-names>G.E.</given-names></name></person-group><article-title>Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases</article-title><source>Toxicol. Appl Pharmacol.</source><volume>134</volume><year>1995</year><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">7676443</pub-id></element-citation></ref><ref id="bib0040"><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>M.F.</given-names></name><name><surname>Kojima</surname><given-names>M.</given-names></name><name><surname>Callicott</surname><given-names>J.H.</given-names></name><name><surname>Goldberg</surname><given-names>T.E.</given-names></name><name><surname>Kolachana</surname><given-names>B.S.</given-names></name><name><surname>Bertolino</surname><given-names>A.</given-names></name><name><surname>Zaitsev</surname><given-names>E.</given-names></name><name><surname>Gold</surname><given-names>B.</given-names></name><name><surname>Goldman</surname><given-names>D.</given-names></name><name><surname>Dean</surname><given-names>M.</given-names></name><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Weinberger</surname><given-names>D.R.</given-names></name></person-group><article-title>The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function</article-title><source>Cell</source><volume>112</volume><year>2003</year><fpage>257</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">12553913</pub-id></element-citation></ref><ref id="bib0045"><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>S.F.</given-names></name><name><surname>Irmady</surname><given-names>K.</given-names></name><name><surname>Ostrow</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>T.</given-names></name><name><surname>Nykjaer</surname><given-names>A.</given-names></name><name><surname>Saftig</surname><given-names>P.</given-names></name><name><surname>Blobel</surname><given-names>C.</given-names></name><name><surname>Hempstead</surname><given-names>B.L.</given-names></name></person-group><article-title>Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation</article-title><source>J. Biological. Chem.</source><volume>286</volume><year>2011</year><fpage>29556</fpage><lpage>29567</lpage></element-citation></ref><ref id="bib0050"><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Ferkany</surname><given-names>J.W.</given-names></name><name><surname>Zaczek</surname><given-names>R.</given-names></name><name><surname>Coyle</surname><given-names>J.T.</given-names></name></person-group><article-title>Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors</article-title><source>Nature</source><volume>298</volume><year>1982</year><fpage>757</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">6287270</pub-id></element-citation></ref><ref id="bib0055"><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Freund</surname><given-names>T.F.</given-names></name><name><surname>Buzs&#x000e1;ki</surname><given-names>G.</given-names></name></person-group><article-title>Interneurons of the hippocampus</article-title><source>Hippocampus</source><volume>6</volume><year>1996</year><fpage>347</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">8915675</pub-id></element-citation></ref><ref id="bib0060"><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.Y.</given-names></name><name><surname>Cao</surname><given-names>Y.M.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Attenuation of MPTP/MPP<sup>+</sup> Toxicity in vivo and in vitro by an 18-mer Peptide Derived from Prosaposin</article-title><source>Neuroscience</source><volume>236</volume><year>2013</year><fpage>373</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">23321539</pub-id></element-citation></ref><ref id="bib0065"><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.Y.</given-names></name><name><surname>Cao</surname><given-names>Y.M.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Decrease in prosaposin in the dystrophic mdx mouse brain</article-title><source>PLoS One</source><volume>8</volume><year>2013</year><fpage>e80032</fpage><pub-id pub-id-type="pmid">24244600</pub-id></element-citation></ref><ref id="bib0070"><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Z.Y.</given-names></name><name><surname>Cao</surname><given-names>Y.M.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>An 18-mer Peptide Derived from Prosaposin Ameliorates the Effect of A&#x003b2;1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice</article-title><source>J. Alzheimer Dis.</source><volume>53</volume><year>2016</year><fpage>1173</fpage><lpage>1192</lpage></element-citation></ref><ref id="bib0075"><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Gillen</surname><given-names>C.</given-names></name><name><surname>Gleichmann</surname><given-names>M.</given-names></name><name><surname>Spreyer</surname><given-names>P.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>H.W.</given-names></name></person-group><article-title>Differentially expressed genes after peripheral nerve injury</article-title><source>J Neurosci Res</source><volume>42</volume><year>1995</year><fpage>159</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">8568916</pub-id></element-citation></ref><ref id="bib0080"><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T.</given-names></name><name><surname>Volk</surname><given-names>D.W.</given-names></name><name><surname>Eggan</surname><given-names>S.M.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><name><surname>Pierri</surname><given-names>J.N.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Sampson</surname><given-names>A.R.</given-names></name><name><surname>Lewis</surname><given-names>D.A.</given-names></name></person-group><article-title>Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia</article-title><source>J. Neurosci.</source><volume>23</volume><year>2003</year><fpage>6315</fpage><lpage>6326</lpage><pub-id pub-id-type="pmid">12867516</pub-id></element-citation></ref><ref id="bib0085"><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Heggli</surname><given-names>D.E.</given-names></name><name><surname>Aamodt</surname><given-names>A.</given-names></name><name><surname>Malthe-S&#x000f8;renssen</surname><given-names>D.</given-names></name></person-group><article-title>Kainic acid neurotxicity; effect of systemic injection on neurotransmitter markers in different brain regions</article-title><source>Brain Res.</source><volume>230</volume><year>1981</year><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">6119136</pub-id></element-citation></ref><ref id="bib0090"><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Hineno</surname><given-names>T.A.</given-names></name><name><surname>Sano</surname><given-names>K.</given-names></name><name><surname>Kondoh</surname><given-names>S.</given-names></name><name><surname>Ueno</surname><given-names>Y.</given-names></name><name><surname>Kakimoto</surname><given-names>K.</given-names></name><name><surname>Yoshida</surname><given-names>K.</given-names></name></person-group><article-title>Secretion of sphingolipid hydrolase activator precursor, prosaposin</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>176</volume><year>1991</year><fpage>668</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">2025281</pub-id></element-citation></ref><ref id="bib0095"><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Hiraiwa</surname><given-names>M.</given-names></name><name><surname>Soeda</surname><given-names>S.</given-names></name><name><surname>Kishimoto</surname><given-names>Y.</given-names></name><name><surname>O'Brien</surname><given-names>J.S.</given-names></name></person-group><article-title>Binding and transport of gangliosides by prosaposin</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>89</volume><year>1992</year><fpage>11254</fpage><lpage>11258</lpage><pub-id pub-id-type="pmid">1454804</pub-id></element-citation></ref><ref id="bib0100"><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Hiraiwa</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>A.G.</given-names></name><name><surname>Wang</surname><given-names>C.Y.</given-names></name><name><surname>Misasi</surname><given-names>R.</given-names></name><name><surname>Yamauchi</surname><given-names>T.</given-names></name><name><surname>Hozumi</surname><given-names>I.</given-names></name><name><surname>Inuzuka</surname><given-names>T.</given-names></name><name><surname>O'Brien</surname><given-names>J.S.</given-names></name></person-group><article-title>Regulation of gene expression in response to brain injury: enhanced expression and alternative splicing of rat prosaposin (SGP-1) mRNA in injured brain</article-title><source>J. Neurotrauma.</source><volume>20</volume><year>2003</year><fpage>755</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">12965054</pub-id></element-citation></ref><ref id="bib0105"><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Holtschmidt</surname><given-names>H.</given-names></name><name><surname>Sandhoff</surname><given-names>K.</given-names></name><name><surname>Furst</surname><given-names>W.</given-names></name><name><surname>Kwon</surname><given-names>H.Y.</given-names></name><name><surname>Schnabel</surname><given-names>D.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name></person-group><article-title>The organization of the gene for the human cerebroside sulfate activator protein</article-title><source>FEBS Lett.</source><volume>280</volume><year>1991</year><fpage>267</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">2013321</pub-id></element-citation></ref><ref id="bib0110"><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Holtschmidt</surname><given-names>H.</given-names></name><name><surname>Sandhoff</surname><given-names>K.</given-names></name><name><surname>Kwon</surname><given-names>H.Y.</given-names></name><name><surname>Harzer</surname><given-names>K.</given-names></name><name><surname>Nakano</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name></person-group><article-title>Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease</article-title><source>J. Biol. Chem.</source><volume>266</volume><year>1991</year><fpage>7556</fpage><lpage>7560</lpage><pub-id pub-id-type="pmid">2019586</pub-id></element-citation></ref><ref id="bib0115"><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Hosoda</surname><given-names>Y.</given-names></name><name><surname>Miyawaki</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Bing</surname><given-names>X.</given-names></name><name><surname>Terashita</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Araki</surname><given-names>N.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Hamada</surname><given-names>F.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Tanabe</surname><given-names>H.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Distribution of prosaposin in the rat nervous system</article-title><source>Cell Tissue Res.</source><volume>330</volume><year>2007</year><fpage>197</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">17763872</pub-id></element-citation></ref><ref id="bib0120"><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Kishimoto</surname><given-names>Y.</given-names></name><name><surname>Hiraiwa</surname><given-names>M.</given-names></name><name><surname>O'Brien</surname><given-names>J.S.</given-names></name></person-group><article-title>Saposins: structure, function, distribution, and molecular genetics</article-title><source>J. Lipid Res.</source><volume>33</volume><year>1992</year><fpage>1255</fpage><lpage>1267</lpage><pub-id pub-id-type="pmid">1402395</pub-id></element-citation></ref><ref id="bib0125"><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Kondoh</surname><given-names>K.</given-names></name><name><surname>Hineno</surname><given-names>T.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Kakimoto</surname><given-names>Y.</given-names></name></person-group><article-title>Isolation and characterization of prosaposin from human milk</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>181</volume><year>1991</year><fpage>286</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">1958198</pub-id></element-citation></ref><ref id="bib0130"><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Kondoh</surname><given-names>K.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Kakimoto</surname><given-names>Y.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Sakanaka</surname><given-names>M.</given-names></name></person-group><article-title>Distribution of prosaposin-like immunoreactivity in rat brain</article-title><source>J. Comp. Neurol.</source><volume>334</volume><year>1993</year><fpage>590</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">8408767</pub-id></element-citation></ref><ref id="bib0135"><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Kotani</surname><given-names>Y.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Sakanaka</surname><given-names>M.</given-names></name><name><surname>Kondoh</surname><given-names>K.</given-names></name><name><surname>Ueno</surname><given-names>S.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name></person-group><article-title>Prosaposin facilitates sciatic nerve regeneration in vivo</article-title><source>J. Neurochem.</source><volume>66</volume><year>1996</year><fpage>2019</fpage><lpage>2025</lpage><pub-id pub-id-type="pmid">8780031</pub-id></element-citation></ref><ref id="bib0140"><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Kotani</surname><given-names>Y.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Wen</surname><given-names>T.C.</given-names></name><name><surname>Sakanaka</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>J.</given-names></name><name><surname>Maeda</surname><given-names>N.</given-names></name><name><surname>Kondoh</surname><given-names>K.</given-names></name><name><surname>Ueno</surname><given-names>S.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name></person-group><article-title>A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo</article-title><source>J. Neurochem.</source><volume>66</volume><year>1996</year><fpage>2197</fpage><lpage>2200</lpage><pub-id pub-id-type="pmid">8780053</pub-id></element-citation></ref><ref id="bib0145"><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>L&#x000e9;vesque</surname><given-names>M.</given-names></name><name><surname>Avoli</surname><given-names>M.</given-names></name></person-group><article-title>The kainic acid model of temporal lobe epilepsy</article-title><source>Neurosci. Biobehav. Rev.</source><volume>37</volume><year>2013</year><fpage>2887</fpage><lpage>2899</lpage><pub-id pub-id-type="pmid">24184743</pub-id></element-citation></ref><ref id="bib0150"><element-citation publication-type="journal" id="sbref0150"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>H.L.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Hamada</surname><given-names>F.</given-names></name><name><surname>Araki</surname><given-names>H.</given-names></name><name><surname>Cao</surname><given-names>Y.M.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Prosaposin expression in the regenerated muscles of mdx and cardiotoxin-treated mice</article-title><source>Histol. Histopathol.</source><volume>28</volume><year>2013</year><fpage>875</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">23325523</pub-id></element-citation></ref><ref id="bib0155"><element-citation publication-type="journal" id="sbref0155"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>R.</given-names></name><name><surname>Pang</surname><given-names>Z.P.</given-names></name><name><surname>Deng</surname><given-names>P.</given-names></name><name><surname>Xu</surname><given-names>Z.C.</given-names></name></person-group><article-title>Transient enhancement of inhibitory synaptic transmission in hippocampal CA1 pyramidal neurons after cerebral ischemia</article-title><source>Neurocience</source><volume>160</volume><year>2009</year><fpage>412</fpage><lpage>418</lpage></element-citation></ref><ref id="bib0160"><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Lothman</surname><given-names>E.W.</given-names></name><name><surname>Collins</surname><given-names>R.C.</given-names></name></person-group><article-title>Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates</article-title><source>Brain Res.</source><volume>218</volume><year>1981</year><fpage>299</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">7272738</pub-id></element-citation></ref><ref id="bib0165"><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name><name><surname>Zaitsev</surname><given-names>E.</given-names></name><name><surname>Snell</surname><given-names>C.R.</given-names></name><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Loh</surname><given-names>Y.P.</given-names></name></person-group><article-title>Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase e</article-title><source>Neuron</source><volume>45</volume><year>2005</year><fpage>245</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">15664176</pub-id></element-citation></ref><ref id="bib0170"><element-citation publication-type="journal" id="sbref0170"><person-group person-group-type="author"><name><surname>Malva</surname><given-names>J.O.</given-names></name><name><surname>Carvalho</surname><given-names>A.P.</given-names></name><name><surname>Carvalho</surname><given-names>C.M.</given-names></name></person-group><article-title>Kainate receptors in hippocampal CA3 subregion: evidence for a role in regulating neurotransmitter release</article-title><source>Neurochem. Int.</source><volume>32</volume><year>1998</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9460695</pub-id></element-citation></ref><ref id="bib0175"><element-citation publication-type="journal" id="sbref0175"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>R.C.</given-names></name><name><surname>Giddens</surname><given-names>M.M.</given-names></name><name><surname>Schaefer</surname><given-names>S.A.</given-names></name><name><surname>Hall</surname><given-names>R.A.</given-names></name></person-group><article-title>GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>110</volume><year>2013</year><fpage>9529</fpage><lpage>9534</lpage><pub-id pub-id-type="pmid">23690594</pub-id></element-citation></ref><ref id="bib0180"><element-citation publication-type="journal" id="sbref0180"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>R.C.</given-names></name><name><surname>Giddens</surname><given-names>M.M.</given-names></name><name><surname>Coleman</surname><given-names>B.M.</given-names></name><name><surname>Hall</surname><given-names>R.A.</given-names></name></person-group><article-title>The protective role of prosaposin and its receptors in the nervous system</article-title><source>Brain Res.</source><volume>1585</volume><year>2014</year><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">25130661</pub-id></element-citation></ref><ref id="bib0185"><element-citation publication-type="journal" id="sbref0185"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>T.</given-names></name><name><surname>Yamasaki</surname><given-names>M.</given-names></name><name><surname>Uchigashima</surname><given-names>M.</given-names></name><name><surname>Matsushima</surname><given-names>A.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name></person-group><article-title>Cellular expression and subcellular localization of secretogranin II in the mouse hippocampus and cerebellum</article-title><source>Eur. J. Neurosci.</source><volume>33</volume><year>2011</year><fpage>82</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">21044184</pub-id></element-citation></ref><ref id="bib0190"><element-citation publication-type="journal" id="sbref0190"><person-group person-group-type="author"><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Uematsu</surname><given-names>K.</given-names></name><name><surname>Takechi</surname><given-names>H.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Yamamiya</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Doihara</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Prosaposin Overexpression following Kainic Acid-Induced Neurotoxicity</article-title><source>PLoS One</source><volume>9</volume><year>2014</year><fpage>e110534</fpage><pub-id pub-id-type="pmid">25461957</pub-id></element-citation></ref><ref id="bib0195"><element-citation publication-type="journal" id="sbref0195"><person-group person-group-type="author"><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Doihara</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Wakisaka</surname><given-names>H.</given-names></name><name><surname>Hamada</surname><given-names>F.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>A Prosaposin-Derived Peptide Alleviates Kainic Acid-Induced Brain Injury</article-title><source>PLoS One</source><volume>10</volume><year>2015</year><fpage>e0126856</fpage><pub-id pub-id-type="pmid">25993033</pub-id></element-citation></ref><ref id="bib0200"><element-citation publication-type="journal" id="sbref0200"><person-group person-group-type="author"><name><surname>Nadler</surname><given-names>J.V.</given-names></name><name><surname>Cuthbertson</surname><given-names>G.J.</given-names></name></person-group><article-title>Kainic acid neurotoxicity toward hippocampal formation: dependence on specific excitatory pathways</article-title><source>Brain Res.</source><volume>195</volume><year>1980</year><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">6249441</pub-id></element-citation></ref><ref id="bib0205"><element-citation publication-type="journal" id="sbref0205"><person-group person-group-type="author"><name><surname>Nadler</surname><given-names>J.V.</given-names></name><name><surname>Evenson</surname><given-names>D.A.</given-names></name><name><surname>Cuthbertson</surname><given-names>G.J.</given-names></name></person-group><article-title>Comparative toxicity of kainic acid and other acidic amino acids toward rat hippocampal neurons</article-title><source>Neuroscience</source><volume>6</volume><year>1981</year><fpage>2505</fpage><lpage>2517</lpage><pub-id pub-id-type="pmid">6275297</pub-id></element-citation></ref><ref id="bib0210"><element-citation publication-type="journal" id="sbref0210"><person-group person-group-type="author"><name><surname>Nakazawa</surname><given-names>K.</given-names></name><name><surname>Zsiros</surname><given-names>V.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Nakao</surname><given-names>K.</given-names></name><name><surname>Kolata</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Belforte</surname><given-names>J.E.</given-names></name></person-group><article-title>GABAergic interneuron origin of schizophrenia pathophysiology</article-title><source>Neuropharmacology</source><volume>62</volume><year>2012</year><fpage>1574</fpage><lpage>1583</lpage><pub-id pub-id-type="pmid">21277876</pub-id></element-citation></ref><ref id="bib0215"><element-citation publication-type="journal" id="sbref0215"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>J.S.</given-names></name><name><surname>Kretz</surname><given-names>K.A.</given-names></name><name><surname>Dewji</surname><given-names>N.</given-names></name><name><surname>Wenger</surname><given-names>D.A.</given-names></name><name><surname>Esch</surname><given-names>F.</given-names></name><name><surname>Fluharty</surname><given-names>A.L.</given-names></name></person-group><article-title>Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus</article-title><source>Science</source><volume>241</volume><year>1988</year><fpage>1098</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">2842863</pub-id></element-citation></ref><ref id="bib0220"><element-citation publication-type="journal" id="sbref0220"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>J.S.</given-names></name><name><surname>Kishimoto</surname><given-names>Y.</given-names></name></person-group><article-title>Saposin proteins: structure, function, and role in human lysosomal storage disorders</article-title><source>FASEB J.</source><volume>5</volume><year>1991</year><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">2001789</pub-id></element-citation></ref><ref id="bib0225"><element-citation publication-type="journal" id="sbref0225"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>J.S.</given-names></name><name><surname>Carson</surname><given-names>G.S.</given-names></name><name><surname>Seo</surname><given-names>H.C.</given-names></name><name><surname>Hiraiwa</surname><given-names>M.</given-names></name><name><surname>Kishimoto</surname><given-names>Y.</given-names></name></person-group><article-title>Identification of prosaposin as a neurotrophic factor</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>91</volume><year>1994</year><fpage>9539</fpage><lpage>9596</lpage><pub-id pub-id-type="pmid">7524080</pub-id></element-citation></ref><ref id="bib0230"><element-citation publication-type="journal" id="sbref0230"><person-group person-group-type="author"><name><surname>Olney</surname><given-names>J.W.</given-names></name><name><surname>de Gubareff</surname><given-names>T.</given-names></name></person-group><article-title>Glutamate neurotoxicity and Huntington's chorea</article-title><source>Nature</source><volume>271</volume><year>1978</year><fpage>557</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">146165</pub-id></element-citation></ref><ref id="bib0235"><element-citation publication-type="journal" id="sbref0235"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>Grabowski</surname><given-names>G.A.</given-names></name></person-group><article-title>Molecular and cell biology of acid beta-glucosidase and prosaposin</article-title><source>Prog. Nucl. Acid Res. Mol. Biol.</source><volume>66</volume><year>2001</year><fpage>203</fpage><lpage>239</lpage></element-citation></ref><ref id="bib0240"><element-citation publication-type="journal" id="sbref0240"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>P.</given-names></name><name><surname>Fumagalli</surname><given-names>G.</given-names></name><name><surname>Zanini</surname><given-names>A.</given-names></name><name><surname>Huttner</surname><given-names>W.B.</given-names></name></person-group><article-title>The major tyrosine-sulfated protein of the bovine anterior pituitary is a secretory protein present in gonadotrophs, thyrotrophs, mammotrophs, and corticotrophs</article-title><source>J. Cell. Biol.</source><volume>100</volume><year>1985</year><fpage>928</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">3972902</pub-id></element-citation></ref><ref id="bib0245"><element-citation publication-type="journal" id="sbref0245"><person-group person-group-type="author"><name><surname>S&#x000ed;k</surname><given-names>A.</given-names></name><name><surname>Penttonen</surname><given-names>M.</given-names></name><name><surname>Ylinen</surname><given-names>A.</given-names></name><name><surname>Buz&#x000e1;ki</surname><given-names>G.</given-names></name></person-group><article-title>Hippocampal CA1 interneurons: an in vivo intracellular labeling study</article-title><source>J. Neuroci.</source><volume>15</volume><year>1995</year><fpage>6651</fpage><lpage>6665</lpage></element-citation></ref><ref id="bib0250"><element-citation publication-type="journal" id="sbref0250"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Saito</surname><given-names>K.</given-names></name><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Differential expression of the alternatively spliced forms of prosaposin mRNAs in the rat choroid plexus</article-title><source>Cell Tissue Res.</source><volume>356</volume><year>2014</year><fpage>231</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">24414178</pub-id></element-citation></ref><ref id="bib0255"><element-citation publication-type="journal" id="sbref0255"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Radin</surname><given-names>N.S.</given-names></name><name><surname>Johnson</surname><given-names>L.L.</given-names></name><name><surname>Tarr</surname><given-names>G.E.</given-names></name></person-group><article-title>The activator protein for glucosylceramide &#x003b2;-glucosidase from guinea pig liver</article-title><source>J. Biol. Chem.</source><volume>263</volume><year>1988</year><fpage>19597</fpage><lpage>19601</lpage><pub-id pub-id-type="pmid">3198642</pub-id></element-citation></ref><ref id="bib0260"><element-citation publication-type="journal" id="sbref0260"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Hineno</surname><given-names>T.</given-names></name><name><surname>Mizuno</surname><given-names>T.</given-names></name><name><surname>Kondoh</surname><given-names>K.</given-names></name><name><surname>Ueno</surname><given-names>S.</given-names></name><name><surname>Kakimoto</surname><given-names>Y.</given-names></name><name><surname>Inui</surname><given-names>K.</given-names></name></person-group><article-title>Sphingolipid hydrolase activator proteins and their precursors</article-title><source>Biochem. Biophys. Res. Commum.</source><volume>165</volume><year>1989</year><fpage>1191</fpage><lpage>1197</lpage></element-citation></ref><ref id="bib0265"><element-citation publication-type="journal" id="sbref0265"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Mizuno</surname><given-names>T.</given-names></name><name><surname>Kondoh</surname><given-names>K.</given-names></name><name><surname>Hineno</surname><given-names>T.</given-names></name><name><surname>Ueno</surname><given-names>S.</given-names></name><name><surname>Kakimoto</surname><given-names>Y.</given-names></name><name><surname>Morita</surname><given-names>N.</given-names></name></person-group><article-title>Saposin-C from bovine spleen: complete amino acid sequence and relation between the structure and its biological activity</article-title><source>Biochem. Biophys. Acta</source><volume>1120</volume><year>1992</year><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">1554743</pub-id></element-citation></ref><ref id="bib0270"><element-citation publication-type="journal" id="sbref0270"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Wen</surname><given-names>T.C.</given-names></name><name><surname>Kotani</surname><given-names>Y.</given-names></name><name><surname>Kondoh</surname><given-names>K.</given-names></name><name><surname>Ueno</surname><given-names>S.</given-names></name><name><surname>Kakimoto</surname><given-names>Y.</given-names></name><name><surname>Yoshimura</surname><given-names>H.</given-names></name><name><surname>Sakanaka</surname><given-names>M.</given-names></name></person-group><article-title>Protection by prosaposin against ischemia-induced learning disability and neuronal loss</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>204</volume><year>1994</year><fpage>994</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">7980569</pub-id></element-citation></ref><ref id="bib0275"><element-citation publication-type="journal" id="sbref0275"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K.</given-names></name><name><surname>Tohyama</surname><given-names>M.</given-names></name></person-group><article-title>Assessment of distribution of cloned ion channels in neuronal tissues</article-title><source>Methods Enzymol.</source><volume>293</volume><year>1998</year><fpage>155</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">9711608</pub-id></element-citation></ref><ref id="bib0280"><element-citation publication-type="journal" id="sbref0280"><person-group person-group-type="author"><name><surname>Schwob</surname><given-names>J.E.</given-names></name><name><surname>Fuller</surname><given-names>T.</given-names></name><name><surname>Price</surname><given-names>J.L.</given-names></name><name><surname>Olney</surname><given-names>J.W.</given-names></name></person-group><article-title>Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study</article-title><source>Neuroscience</source><volume>5</volume><year>1980</year><fpage>991</fpage><lpage>1014</lpage><pub-id pub-id-type="pmid">7402461</pub-id></element-citation></ref><ref id="bib0285"><element-citation publication-type="journal" id="sbref0285"><person-group person-group-type="author"><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Yamamiya</surname><given-names>K.</given-names></name><name><surname>Wakisaka</surname><given-names>H.</given-names></name><name><surname>Takeuchi</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Distribution of prosaposin in rat lymphatic tissues</article-title><source>Cell Tissue Res.</source><volume>352</volume><year>2013</year><fpage>685</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">23420452</pub-id></element-citation></ref><ref id="bib0290"><element-citation publication-type="journal" id="sbref0290"><person-group person-group-type="author"><name><surname>Sorice</surname><given-names>M.</given-names></name><name><surname>Molinari</surname><given-names>S.</given-names></name><name><surname>Di Marzio</surname><given-names>L.</given-names></name><name><surname>Mattei</surname><given-names>V.</given-names></name><name><surname>Tasciotti</surname><given-names>V.</given-names></name><name><surname>Ciarlo</surname><given-names>L.</given-names></name><name><surname>Hiraiwa</surname><given-names>M.</given-names></name><name><surname>Garofalo</surname><given-names>T.</given-names></name><name><surname>Misasi</surname><given-names>R.</given-names></name></person-group><article-title>Neurotrophic signalling pathway triggered by prosaposin in PC12 cells occurs through lipid rafts</article-title><source>FEBS J.</source><volume>275</volume><year>2008</year><fpage>4903</fpage><lpage>4912</lpage><pub-id pub-id-type="pmid">18761669</pub-id></element-citation></ref><ref id="bib0295"><element-citation publication-type="journal" id="sbref0295"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>A.Y.</given-names></name><name><surname>Chen</surname><given-names>Y.M.</given-names></name></person-group><article-title>Oxidative stress and neurodegenerative disorders</article-title><source>J. Biomed. Sci.</source><volume>5</volume><year>1998</year><fpage>401</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">9845843</pub-id></element-citation></ref><ref id="bib0300"><element-citation publication-type="journal" id="sbref0300"><person-group person-group-type="author"><name><surname>Terashita</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Miyawaki</surname><given-names>K.</given-names></name><name><surname>Hyodo</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>K.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Gyo</surname><given-names>K.</given-names></name></person-group><article-title>Localization of prosaposin in rat cochlea</article-title><source>Neurosci. Res.</source><volume>57</volume><year>2007</year><fpage>372</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">17156877</pub-id></element-citation></ref><ref id="bib0305"><element-citation publication-type="journal" id="sbref0305"><person-group person-group-type="author"><name><surname>Tsuboi</surname><given-names>K.</given-names></name><name><surname>Hiraiwa</surname><given-names>M.</given-names></name><name><surname>O'Brien</surname><given-names>J.S.</given-names></name></person-group><article-title>Prosaposin prevents programmed cell death of rat cerebellar granule neurons in culture</article-title><source>Brain Res. Dev. Brain Res.</source><volume>110</volume><year>1998</year><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">9748612</pub-id></element-citation></ref><ref id="bib0310"><element-citation publication-type="journal" id="sbref0310"><person-group person-group-type="author"><name><surname>Unuma</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>K.</given-names></name><name><surname>Wakisaka</surname><given-names>H.</given-names></name><name><surname>Mominoki</surname><given-names>K.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Changes in expression of prosaposin in the rat facial nerve nucleus after facial nerve transection</article-title><source>Neurosci. Res.</source><volume>52</volume><year>2005</year><fpage>220</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">15927723</pub-id></element-citation></ref><ref id="bib0315"><element-citation publication-type="journal" id="sbref0315"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Simonyi</surname><given-names>A.</given-names></name><name><surname>Sun</surname><given-names>G.Y.</given-names></name><name><surname>Sun</surname><given-names>A.Y.</given-names></name></person-group><article-title>Kainic acid-mediated excitotoxicity as a model for neurodegeneration</article-title><source>Mol. Neurobiol.</source><volume>31</volume><year>2005</year><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">15953808</pub-id></element-citation></ref><ref id="bib0320"><element-citation publication-type="journal" id="sbref0320"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Shimokawa</surname><given-names>T.</given-names></name><name><surname>Nabeka</surname><given-names>H.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name></person-group><article-title>Chronological changes in prosaposin in the developing rat brain</article-title><source>Neurosci. Res.</source><volume>71</volume><year>2011</year><fpage>22</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">21684311</pub-id></element-citation></ref><ref id="bib0325"><element-citation publication-type="journal" id="sbref0325"><person-group person-group-type="author"><name><surname>Yokota</surname><given-names>N.</given-names></name><name><surname>Uchijima</surname><given-names>M.</given-names></name><name><surname>Nishizawa</surname><given-names>S.</given-names></name><name><surname>Namba</surname><given-names>H.</given-names></name><name><surname>Koide</surname><given-names>Y.</given-names></name></person-group><article-title>Identification of differentially expressed genes in rat hippocampus after transient global cerebral ischemia using subtractive cDNA cloning based on polymerase chain reaction</article-title><source>Stroke</source><volume>32</volume><year>2001</year><fpage>168</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">11136933</pub-id></element-citation></ref><ref id="bib0330"><element-citation publication-type="journal" id="sbref0330"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>L.</given-names></name><name><surname>Morales</surname><given-names>C.R.</given-names></name></person-group><article-title>Prosaposin sorting is mediated by oligomerization</article-title><source>Exp. Cell Res.</source><volume>317</volume><year>2011</year><fpage>2456</fpage><lpage>2467</lpage><pub-id pub-id-type="pmid">21835174</pub-id></element-citation></ref></ref-list><ack id="ack0005"><title>Aknowlegements</title><p>This study was supported by the <funding-source id="gs0005">Ehime University INCS</funding-source> and in part by a grant to HN from Ehime University, and <funding-source id="gs0010">JSPS KAKENHI</funding-source> to MK (15K20005), and SM (22591637). The authors wish to thank D Shimizu for his excellent technical support.</p></ack></back></article>